Apellis Pharmaceuticals Aktie
15,96
EUR
+0,78
EUR
+5,17
%
18,21
USD
+0,25
USD
+1,36
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
12.04.18 | Apellis Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung